STOCK TITAN

CBLL - CBLL STOCK NEWS

Welcome to our dedicated page for CBLL news (Ticker: CBLL), a resource for investors and traders seeking the latest updates and insights on CBLL stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CBLL's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CBLL's position in the market.

Rhea-AI Summary

CeriBell, Inc. (Nasdaq: CBLL), a commercial-stage medical technology company, has announced the pricing of its upsized initial public offering. The company is offering 10,606,060 shares of common stock at a public offering price of $17.00 per share. CeriBell has also granted underwriters a 30-day option to purchase up to an additional 1,590,909 shares at the initial offering price.

Trading of the shares is expected to begin on the Nasdaq Global Select Market on October 11, 2024, under the ticker symbol 'CBLL'. The gross proceeds from the offering are anticipated to be approximately $180.3 million, excluding any exercise of the underwriters' option. The offering is expected to close on October 15, 2024, subject to customary closing conditions.

BofA Securities and J.P. Morgan are acting as joint book-running managers and representatives of the underwriters, with William Blair, TD Cowen, and Canaccord Genuity serving as co-managers for the offering.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
CBLL

Nasdaq:CBLL

CBLL Rankings

CBLL Stock Data